- FOUNDED 1977
Overview
The Gastrointestinal Cancer Group helps to ensure COSA remains appropriately connected and at the forefront of the cancer control agenda, especially as it relates to gastrointestinal cancers by ensuring the discipline is represented on COSA Council – our main scientific and advisory body representing all COSA Members.
Gastrointestinal cancers are well represented throughout the COSA membership and our Affiliated Organisations, therefore the COSA Gastrointestinal Cancer Group is not currently undertaking any specific COSA projects.
The Gastrointestinal Group is open to gastroenterologists, surgeons, medical oncologists, radiation oncologists, medical specialists, nurses, stoma care providers, researchers and other health care professionals with an interest in the management of both colorectal and upper gastrointestinal malignancies.
The aim of the Group is to promote education of health care professionals and the public on gastrointestinal oncology. The Group also advocates for improvements in public health policy, particularly with regard to screening for colorectal cancer, and participates in the development of best practice guidelines.
The Group has strong links to the COSA Affiliated Organisation the Australasian Gastrointestinal Trials Group (AGITG).
What’s the latest
Group Chair
Group Chair
Connie Diakos
Gastrointestinal Cancer Group Chair
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow
COSAoncology 2 days ago
You have till this Friday 22 Nov '24 to submit an abstract for the National Cancer Survivorship Conference #Surv25 in Melbourne, 6-7 March. We particularly welcome submissions from survivors themselves and those whose work is in partnership with survivors https://t.co/6V4F3x1vvF https://t.co/vjp4hfcVXN
Read More >
COSAoncology 3 days ago
You have till this Friday 22 Nov '24 to submit an abstract for the National Cancer Survivorship Conference #Surv25 to be held in Melbourne, March 2025. We particularly welcome submissions from survivors and those whose work is in partnership with survivors https://t.co/6V4F3x1vvF https://t.co/87PUAMTxwA
Read More >
COSAoncology 6 days ago
It's a wrap! Thanks to everyone who made #COSA24 a huge success, not least the almost 900 delegates who joined us on the Gold Coast. Watch the video for all the stats. https://t.co/ysZNul66qH
Read More >
COSAoncology 6 days ago
@sdent_cardioonc spent many years providing cancer care in Ontario Canada and was delighted to take home @garvey_gail's 'Indigenous and Tribal Peoples and Cancer' from #COSA24. @sdent_cardioonc shared her expertise on cardiovascular multimorbidity and cancer at the ASM. https://t.co/1Db1QSn3py
Read More >
COSAoncology 6 days ago
Job well done! #COSA24 Co-convenors Michael Powell and Sean Hill delivered an amazing meeting. Time to relax ... almost. See what's left on the program https://t.co/ACGrZGt2Ee https://t.co/NVi9bY1fiL
Read More >
COSAoncology 6 days ago
You won't want to miss the #COSA24 plenary on AI in Healthcare with presenters @thedeanh @dhansen35 and Prof Catherine Jones. Followed by a panel discussion at Q&A. Today at 1:30pm https://t.co/AEgtwaqSIS
Read More >
COSAoncology 6 days ago
Congratulations to the winner of the Best of the Best Oral presentation on Education at #COSA24 Grace Gard. https://t.co/jn4TmaifII
Read More >
COSAoncology 7 days ago
Congratulations to the tied winners of the Best of the Best Oral presentation on Clinical Research at #COSA24 Bishma Jayathilaka and Belinda Sassé. https://t.co/E8XTcBsRSq
Read More >
COSAoncology 7 days ago
@sdent_cardioonc spent years providing cancer care in Ontario Canada and was thrilled to take home a copy of @garvey_gail's 'Indigenous and Tribal Peoples with Cancer' from #COSA24. @sdent_cardioonc shared her expertise in cardiovascular multimorbidity and cancer at the ASM https://t.co/mBYaLc5qQ4
Read More >
COSAoncology 7 days ago
Congratulations to the winner of the Best of the Best Oral Rapid Fire presentation on 'Rare and less common cancers' at #COSA24 Ashleigh R Sharman. https://t.co/sOHBUDJvtW
Read More >